bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.09.14.557840

Localgini: A method for harnessing inequality in geneexpression to improve the quality of context-specific models

Abstract

Genome-scale metabolic models (GEMs) are valuable tools for investigating normal and disease phenotypes of biological systems through the prediction of fluxes in biochemical reactions. However, in specific contexts such as different cell lines, tissues, or diseases, only a subset of reactions is active. To address this, several model extraction methods (MeMs) have been developed to filter the reactions in GEMs and extract context-specific models. These methods utilize gene expression data as a source of context-specific information. To construct context-specific models, MeMs require core reactions specific to the given context as input. Typically, core reactions are derived using a single threshold applied to gene expression data. Reactions associated with genes whose expression values exceed the threshold are considered as core reactions. However, it is important to note that enzyme activity is not solely determined by gene expression levels. This approach based on a single threshold may inadvertently exclude reactions that require enzymes in smaller quantities. In this study, we propose a novel thresholding algorithm called Localgini, which leverages the Gini coefficient and transcriptomics data to derive gene-specific thresholds. Localgini is implemented as a pre-processing step to obtain core reactions for MeMs. To demonstrate the effectiveness of Localgini, we construct context-specific models for NCI-60 cancer cell lines and human tissues using different MeMs. We compare the performance of Localgini with existing thresholding methods, namely LocalT2 and StanDep. The results show that the models derived using Localgini recover a greater number of housekeeping functionalities compared to the other thresholding methods. Moreover, the Localgini-derived core reactions exhibit increased self-consistency and display enhanced consensus among models built using different MeMs. By incorporating transcriptomic support, Localgini includes low-expression reactions in the core reaction list, enhancing the comprehensiveness of the resulting models. Codes used in this study, compatible with COBRA toolbox are available at https://github.com/NiravBhattLab/Localgini Author summaryGenome-scale models are becoming a desirable tool to understand the metabolism of a biological system and hence find applications in the fields of systems and synthetic biology. These models are often integrated with transcriptomics data to improve prediction accuracy. Algorithms developed to integrate transcriptomics data with genome-scale models require core reactions to be derived from omics data using a threshold. In this work, we propose a thresholding method that uses an inequality-based metric to derive thresholds. We implied the proposed method and other existing methods to datasets of cancer cell lines and human tissue. We showed that our method improves the inclusion of reactions required for basic cellular maintenance. Furthermore, we validated the built models for the reduction in variance owing to the model-extraction algorithms. Overall, the proposed method improves the quality of metabolic models by inferring inequality in the distribution of gene expression levels across samples/contexts.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kumar S, P., Bhatt, N.. 2023-09-17. Localgini: A method for harnessing inequality in geneexpression to improve the quality of context-specific models. https://doi.org/10.1101/2023.09.14.557840

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology↗

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology↗

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology↗